Information Provided By:
Fly News Breaks for July 29, 2015
EW
Jul 29, 2015 | 07:43 EDT
Leerink raised its price target for Edwards Lifesciences to $185 saying faster market growth drove the better than expected Q2 results. The firm keeps an Outperform rating on the stock.